Professor Oliver Schnell
Sciarc GmbH, Munich (Germany)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
ACR and lipid point-of-care testing as tools for CVD prediction and management.
Event: ESC Congress 2022
Topic: Prevention
Session: Prevention of cardiovascular diseases in the post-COVID19 era
Interactive panel discussion
Event: ESC Congress 2019
Topic: Diabetes and the Heart
Session: Rewriting the textbooks: SGLT2 inhibitors and cardiovascular disease in type 2 diabetes
Heart failure with and without chronic kidney disease in type 2 diabetes
Event: ESC Congress 2019
Topic: Diabetes and the Heart
Session: Rewriting the textbooks: SGLT2 inhibitors and cardiovascular disease in type 2 diabetes
ESC 365 is supported by
